Poolbeg Pharma announces expansion of POLB 001 into oncology
News release
by
Poolbeg Pharma PLC
London, UK
|
January 18, 2023 08:10 AM Eastern Standard Time
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
